Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$25.26 - $29.6 $1.01 Million - $1.18 Million
-40,000 Reduced 13.79%
250,000 $7 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $699,030 - $802,710
-27,000 Reduced 8.52%
290,000 $8.05 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $8.28 Million - $10.8 Million
317,000 New
317,000 $9.13 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $26 Million - $29.5 Million
-790,000 Reduced 92.94%
60,000 $2.35 Million
Q2 2019

Aug 08, 2019

BUY
$36.98 - $41.52 $24.9 Million - $28 Million
674,000 Added 382.95%
850,000 $36.8 Million
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $8.4 Million - $9.23 Million
-224,000 Reduced 56.0%
176,000 $7.48 Million
Q4 2017

Feb 01, 2018

BUY
$33.26 - $35.29 $13.3 Million - $14.1 Million
400,000
400,000 $14.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.